nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—Estramustine—prostate cancer	0.09	0.272	CrCtD
Estropipate—Estrone—prostate cancer	0.0715	0.216	CrCtD
Estropipate—Conjugated Estrogens—prostate cancer	0.063	0.19	CrCtD
Estropipate—Estradiol—prostate cancer	0.0542	0.163	CrCtD
Estropipate—Ethinyl Estradiol—prostate cancer	0.0529	0.16	CrCtD
Estropipate—ESR2—prostate cancer	0.0392	0.267	CbGaD
Estropipate—SHBG—prostate cancer	0.0357	0.244	CbGaD
Estropipate—SLC22A1—prostate cancer	0.0353	0.241	CbGaD
Estropipate—ESR2—Estramustine—prostate cancer	0.0269	0.138	CbGbCtD
Estropipate—ESR1—prostate cancer	0.0241	0.165	CbGaD
Estropipate—ESR2—Estrone—prostate cancer	0.0173	0.0887	CbGbCtD
Estropipate—ESR2—Ethinyl Estradiol—prostate cancer	0.0154	0.079	CbGbCtD
Estropipate—ESR1—Estramustine—prostate cancer	0.0138	0.0705	CbGbCtD
Estropipate—CYP3A4—prostate cancer	0.0123	0.084	CbGaD
Estropipate—SHBG—Estrone—prostate cancer	0.0123	0.0628	CbGbCtD
Estropipate—ESR2—Conjugated Estrogens—prostate cancer	0.0113	0.058	CbGbCtD
Estropipate—SHBG—Ethinyl Estradiol—prostate cancer	0.0109	0.056	CbGbCtD
Estropipate—ESR2—Estradiol—prostate cancer	0.00994	0.0509	CbGbCtD
Estropipate—ESR1—Estrone—prostate cancer	0.00887	0.0454	CbGbCtD
Estropipate—Estriol—Estramustine—prostate cancer	0.00828	0.037	CrCrCtD
Estropipate—Equilin—Estrone—prostate cancer	0.00804	0.036	CrCrCtD
Estropipate—ESR1—Ethinyl Estradiol—prostate cancer	0.00791	0.0405	CbGbCtD
Estropipate—Equilin—Conjugated Estrogens—prostate cancer	0.00708	0.0317	CrCrCtD
Estropipate—Conjugated Estrogens—Estramustine—prostate cancer	0.00705	0.0315	CrCrCtD
Estropipate—SHBG—Estradiol—prostate cancer	0.00705	0.0361	CbGbCtD
Estropipate—Estramustine—Estrone—prostate cancer	0.00658	0.0294	CrCrCtD
Estropipate—Estriol—Estrone—prostate cancer	0.00658	0.0294	CrCrCtD
Estropipate—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00614	0.0275	CrCrCtD
Estropipate—Estrone—Estradiol valerate/Dienogest—prostate cancer	0.00614	0.0275	CrCrCtD
Estropipate—Equilin—Estradiol—prostate cancer	0.00609	0.0273	CrCrCtD
Estropipate—Equilin—Ethinyl Estradiol—prostate cancer	0.00595	0.0266	CrCrCtD
Estropipate—Ethinyl Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00585	0.0262	CrCrCtD
Estropipate—ESR1—Conjugated Estrogens—prostate cancer	0.0058	0.0297	CbGbCtD
Estropipate—Estriol—Conjugated Estrogens—prostate cancer	0.00579	0.0259	CrCrCtD
Estropipate—Estramustine—Conjugated Estrogens—prostate cancer	0.00579	0.0259	CrCrCtD
Estropipate—Conjugated Estrogens—Estrone—prostate cancer	0.0056	0.0251	CrCrCtD
Estropipate—Estradiol—Estramustine—prostate cancer	0.00522	0.0234	CrCrCtD
Estropipate—Estrone—Estramustine—prostate cancer	0.00522	0.0234	CrCrCtD
Estropipate—Quinestrol—Estramustine—prostate cancer	0.00522	0.0234	CrCrCtD
Estropipate—Mestranol—Estramustine—prostate cancer	0.00522	0.0234	CrCrCtD
Estropipate—Exemestane—Estrone—prostate cancer	0.00522	0.0234	CrCrCtD
Estropipate—ESR1—Estradiol—prostate cancer	0.00509	0.0261	CbGbCtD
Estropipate—Estriol—Estradiol—prostate cancer	0.00498	0.0223	CrCrCtD
Estropipate—Estramustine—Estradiol—prostate cancer	0.00498	0.0223	CrCrCtD
Estropipate—Ethinyl Estradiol—Estramustine—prostate cancer	0.00498	0.0223	CrCrCtD
Estropipate—Estriol—Ethinyl Estradiol—prostate cancer	0.00486	0.0218	CrCrCtD
Estropipate—Estramustine—Ethinyl Estradiol—prostate cancer	0.00486	0.0218	CrCrCtD
Estropipate—Exemestane—Conjugated Estrogens—prostate cancer	0.0046	0.0206	CrCrCtD
Estropipate—Formestane—Estrone—prostate cancer	0.00437	0.0196	CrCrCtD
Estropipate—Conjugated Estrogens—Estradiol—prostate cancer	0.00424	0.019	CrCrCtD
Estropipate—Estradiol—Estrone—prostate cancer	0.00415	0.0186	CrCrCtD
Estropipate—Mestranol—Estrone—prostate cancer	0.00415	0.0186	CrCrCtD
Estropipate—Quinestrol—Estrone—prostate cancer	0.00415	0.0186	CrCrCtD
Estropipate—Conjugated Estrogens—Ethinyl Estradiol—prostate cancer	0.00414	0.0185	CrCrCtD
Estropipate—ALB—Abiraterone—prostate cancer	0.00402	0.0206	CbGbCtD
Estropipate—Ethinyl Estradiol—Estrone—prostate cancer	0.00395	0.0177	CrCrCtD
Estropipate—Formestane—Conjugated Estrogens—prostate cancer	0.00385	0.0172	CrCrCtD
Estropipate—Quinestrol—Conjugated Estrogens—prostate cancer	0.00365	0.0163	CrCrCtD
Estropipate—Mestranol—Conjugated Estrogens—prostate cancer	0.00365	0.0163	CrCrCtD
Estropipate—Estradiol—Conjugated Estrogens—prostate cancer	0.00365	0.0163	CrCrCtD
Estropipate—Estrone—Conjugated Estrogens—prostate cancer	0.00365	0.0163	CrCrCtD
Estropipate—Ethinyl Estradiol—Conjugated Estrogens—prostate cancer	0.00348	0.0156	CrCrCtD
Estropipate—Mestranol—Estradiol—prostate cancer	0.00314	0.0141	CrCrCtD
Estropipate—Quinestrol—Estradiol—prostate cancer	0.00314	0.0141	CrCrCtD
Estropipate—Estrone—Estradiol—prostate cancer	0.00314	0.0141	CrCrCtD
Estropipate—Mestranol—Ethinyl Estradiol—prostate cancer	0.00307	0.0137	CrCrCtD
Estropipate—Quinestrol—Ethinyl Estradiol—prostate cancer	0.00307	0.0137	CrCrCtD
Estropipate—Estrone—Ethinyl Estradiol—prostate cancer	0.00307	0.0137	CrCrCtD
Estropipate—Estradiol—Ethinyl Estradiol—prostate cancer	0.00307	0.0137	CrCrCtD
Estropipate—Ethinyl Estradiol—Estradiol—prostate cancer	0.003	0.0134	CrCrCtD
Estropipate—ALB—Estrone—prostate cancer	0.00291	0.0149	CbGbCtD
Estropipate—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00289	0.0148	CbGbCtD
Estropipate—SLC22A1—Estradiol—prostate cancer	0.00285	0.0146	CbGbCtD
Estropipate—CYP2C9—Bicalutamide—prostate cancer	0.00261	0.0134	CbGbCtD
Estropipate—CYP2C9—Nilutamide—prostate cancer	0.00261	0.0134	CbGbCtD
Estropipate—CYP1A2—Flutamide—prostate cancer	0.0024	0.0123	CbGbCtD
Estropipate—CYP1A2—Estrone—prostate cancer	0.00174	0.0089	CbGbCtD
Estropipate—ALB—Estradiol—prostate cancer	0.00167	0.00855	CbGbCtD
Estropipate—CYP2C9—Estrone—prostate cancer	0.00157	0.00802	CbGbCtD
Estropipate—CYP3A4—Bicalutamide—prostate cancer	0.00152	0.00779	CbGbCtD
Estropipate—SHBG—semen—prostate cancer	0.00151	0.23	CbGeAlD
Estropipate—ALB—Prednisone—prostate cancer	0.00144	0.00735	CbGbCtD
Estropipate—CYP3A4—Estramustine—prostate cancer	0.00141	0.00724	CbGbCtD
Estropipate—Exemestane—Prednisone—prostate cancer	0.00136	0.00607	CrCrCtD
Estropipate—CYP3A4—Flutamide—prostate cancer	0.00126	0.00645	CbGbCtD
Estropipate—CYP3A4—Abiraterone—prostate cancer	0.00126	0.00645	CbGbCtD
Estropipate—CYP2C9—Capecitabine—prostate cancer	0.00119	0.00608	CbGbCtD
Estropipate—CYP1A2—Conjugated Estrogens—prostate cancer	0.00114	0.00583	CbGbCtD
Estropipate—CYP1A2—Estradiol—prostate cancer	0.000999	0.00511	CbGbCtD
Estropipate—CYP3A4—Cabazitaxel—prostate cancer	0.000932	0.00477	CbGbCtD
Estropipate—CYP3A4—Estrone—prostate cancer	0.000911	0.00467	CbGbCtD
Estropipate—CYP2C9—Estradiol—prostate cancer	0.0009	0.00461	CbGbCtD
Estropipate—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000812	0.00416	CbGbCtD
Estropipate—CYP1A2—Etoposide—prostate cancer	0.000652	0.00334	CbGbCtD
Estropipate—CYP3A4—Conjugated Estrogens—prostate cancer	0.000596	0.00305	CbGbCtD
Estropipate—Equilin—HSD17B1—prostate cancer	0.000592	0.373	CrCbGaD
Estropipate—CYP1A2—urine—prostate cancer	0.000573	0.0872	CbGeAlD
Estropipate—CYP2C9—urine—prostate cancer	0.000544	0.0828	CbGeAlD
Estropipate—CYP3A4—Mitoxantrone—prostate cancer	0.000542	0.00277	CbGbCtD
Estropipate—CYP3A4—Estradiol—prostate cancer	0.000523	0.00268	CbGbCtD
Estropipate—CYP3A4—Prednisone—prostate cancer	0.00045	0.0023	CbGbCtD
Estropipate—CYP3A4—urine—prostate cancer	0.000415	0.0631	CbGeAlD
Estropipate—ESR2—prostate gland—prostate cancer	0.00039	0.0593	CbGeAlD
Estropipate—SHBG—prostate gland—prostate cancer	0.000379	0.0576	CbGeAlD
Estropipate—CYP3A4—Etoposide—prostate cancer	0.000342	0.00175	CbGbCtD
Estropipate—CYP3A4—Docetaxel—prostate cancer	0.000313	0.0016	CbGbCtD
Estropipate—ESR2—epithelium—prostate cancer	0.000286	0.0436	CbGeAlD
Estropipate—ESR1—prostate gland—prostate cancer	0.000267	0.0406	CbGeAlD
Estropipate—ESR2—renal system—prostate cancer	0.000266	0.0404	CbGeAlD
Estropipate—CYP3A4—Doxorubicin—prostate cancer	0.000233	0.00119	CbGbCtD
Estropipate—SLC22A1—renal system—prostate cancer	0.000223	0.0339	CbGeAlD
Estropipate—ESR1—epithelium—prostate cancer	0.000196	0.0298	CbGeAlD
Estropipate—SHBG—bone marrow—prostate cancer	0.000195	0.0297	CbGeAlD
Estropipate—ESR1—renal system—prostate cancer	0.000182	0.0277	CbGeAlD
Estropipate—ESR2—testis—prostate cancer	0.000172	0.0261	CbGeAlD
Estropipate—SHBG—testis—prostate cancer	0.000167	0.0254	CbGeAlD
Estropipate—CYP1A2—renal system—prostate cancer	0.00014	0.0213	CbGeAlD
Estropipate—ALB—testis—prostate cancer	0.000138	0.021	CbGeAlD
Estropipate—ESR2—lymph node—prostate cancer	0.000124	0.0189	CbGeAlD
Estropipate—ESR1—testis—prostate cancer	0.000118	0.0179	CbGeAlD
Estropipate—CYP3A4—renal system—prostate cancer	0.000101	0.0154	CbGeAlD
Estropipate—ALB—lymph node—prostate cancer	9.99e-05	0.0152	CbGeAlD
Estropipate—ESR1—lymph node—prostate cancer	8.52e-05	0.013	CbGeAlD
Estropipate—Equilin—SHBG—prostate cancer	7.42e-05	0.0467	CrCbGaD
Estropipate—Ethinyl Estradiol—AOX1—prostate cancer	6.87e-05	0.0432	CrCbGaD
Estropipate—Estriol—ESR2—prostate cancer	5.1e-05	0.0321	CrCbGaD
Estropipate—Quinestrol—ESR1—prostate cancer	4.75e-05	0.0299	CrCbGaD
Estropipate—Estramustine—ESR2—prostate cancer	4.74e-05	0.0298	CrCbGaD
Estropipate—Estriol—SHBG—prostate cancer	4.65e-05	0.0293	CrCbGaD
Estropipate—Estradiol—AOX1—prostate cancer	4.53e-05	0.0285	CrCbGaD
Estropipate—Exemestane—CYP19A1—prostate cancer	4.39e-05	0.0276	CrCbGaD
Estropipate—Mestranol—ESR1—prostate cancer	3.6e-05	0.0227	CrCbGaD
Estropipate—Estriol—ESR1—prostate cancer	3.14e-05	0.0198	CrCbGaD
Estropipate—Estramustine—ESR1—prostate cancer	2.92e-05	0.0184	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR2—prostate cancer	2.79e-05	0.0175	CrCbGaD
Estropipate—Conjugated Estrogens—COMT—prostate cancer	2.61e-05	0.0164	CrCbGaD
Estropipate—Ethinyl Estradiol—SHBG—prostate cancer	2.54e-05	0.016	CrCbGaD
Estropipate—Conjugated Estrogens—ESR2—prostate cancer	2.43e-05	0.0153	CrCbGaD
Estropipate—Estrone—ESR2—prostate cancer	2.43e-05	0.0153	CrCbGaD
Estropipate—Estradiol—SLC22A3—prostate cancer	2.31e-05	0.0145	CrCbGaD
Estropipate—Estrone—SHBG—prostate cancer	2.21e-05	0.0139	CrCbGaD
Estropipate—Estrone—CYP1B1—prostate cancer	2.21e-05	0.0139	CrCbGaD
Estropipate—Exemestane—CYP3A4—prostate cancer	2.06e-05	0.013	CrCbGaD
Estropipate—Estradiol—ESR2—prostate cancer	1.84e-05	0.0116	CrCbGaD
Estropipate—Estrone—CYP3A5—prostate cancer	1.76e-05	0.0111	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR1—prostate cancer	1.72e-05	0.0108	CrCbGaD
Estropipate—Estradiol—CYP1B1—prostate cancer	1.68e-05	0.0106	CrCbGaD
Estropipate—Estradiol—SHBG—prostate cancer	1.68e-05	0.0106	CrCbGaD
Estropipate—Estradiol—SLC22A1—prostate cancer	1.66e-05	0.0104	CrCbGaD
Estropipate—Conjugated Estrogens—ESR1—prostate cancer	1.5e-05	0.00944	CrCbGaD
Estropipate—Estrone—ESR1—prostate cancer	1.5e-05	0.00941	CrCbGaD
Estropipate—Estramustine—CYP3A4—prostate cancer	1.49e-05	0.00938	CrCbGaD
Estropipate—Estradiol—AR—prostate cancer	1.47e-05	0.00926	CrCbGaD
Estropipate—Estradiol—CYP3A5—prostate cancer	1.34e-05	0.00841	CrCbGaD
Estropipate—Estrone—CYP2E1—prostate cancer	1.21e-05	0.00763	CrCbGaD
Estropipate—Estrone—CYP1A1—prostate cancer	1.2e-05	0.00752	CrCbGaD
Estropipate—Estradiol—ESR1—prostate cancer	1.13e-05	0.00713	CrCbGaD
Estropipate—Estradiol—CYP2C19—prostate cancer	9.1e-06	0.00572	CrCbGaD
Estropipate—Estradiol—CYP1A1—prostate cancer	9.06e-06	0.0057	CrCbGaD
Estropipate—Ethinyl Estradiol—CYP3A4—prostate cancer	8.76e-06	0.00551	CrCbGaD
Estropipate—Conjugated Estrogens—CYP3A4—prostate cancer	7.65e-06	0.00482	CrCbGaD
Estropipate—Estrone—CYP3A4—prostate cancer	7.63e-06	0.0048	CrCbGaD
Estropipate—Mental disorder—Prednisone—prostate cancer	6.08e-06	8.84e-05	CcSEcCtD
Estropipate—Diarrhoea—Estradiol—prostate cancer	6.08e-06	8.83e-05	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—prostate cancer	6.05e-06	8.79e-05	CcSEcCtD
Estropipate—Infestation—Epirubicin—prostate cancer	6.05e-06	8.79e-05	CcSEcCtD
Estropipate—Erythema—Prednisone—prostate cancer	6.04e-06	8.79e-05	CcSEcCtD
Estropipate—Malnutrition—Prednisone—prostate cancer	6.04e-06	8.79e-05	CcSEcCtD
Estropipate—Palpitations—Capecitabine—prostate cancer	6e-06	8.72e-05	CcSEcCtD
Estropipate—Myalgia—Docetaxel—prostate cancer	5.97e-06	8.67e-05	CcSEcCtD
Estropipate—Arthralgia—Docetaxel—prostate cancer	5.97e-06	8.67e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—prostate cancer	5.94e-06	8.64e-05	CcSEcCtD
Estropipate—Asthenia—Mitoxantrone—prostate cancer	5.94e-06	8.63e-05	CcSEcCtD
Estropipate—Fatigue—Etoposide—prostate cancer	5.93e-06	8.63e-05	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—prostate cancer	5.93e-06	8.62e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	5.93e-06	8.61e-05	CcSEcCtD
Estropipate—Cough—Capecitabine—prostate cancer	5.92e-06	8.61e-05	CcSEcCtD
Estropipate—Pain—Etoposide—prostate cancer	5.89e-06	8.56e-05	CcSEcCtD
Estropipate—Constipation—Etoposide—prostate cancer	5.89e-06	8.56e-05	CcSEcCtD
Estropipate—Dizziness—Estradiol—prostate cancer	5.87e-06	8.54e-05	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—prostate cancer	5.87e-06	8.53e-05	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—prostate cancer	5.83e-06	8.48e-05	CcSEcCtD
Estropipate—Estradiol—CYP3A4—prostate cancer	5.78e-06	0.00364	CrCbGaD
Estropipate—Arthralgia—Capecitabine—prostate cancer	5.78e-06	8.4e-05	CcSEcCtD
Estropipate—Myalgia—Capecitabine—prostate cancer	5.78e-06	8.4e-05	CcSEcCtD
Estropipate—Anxiety—Capecitabine—prostate cancer	5.76e-06	8.37e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	5.74e-06	8.34e-05	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—prostate cancer	5.72e-06	8.32e-05	CcSEcCtD
Estropipate—Oedema—Docetaxel—prostate cancer	5.72e-06	8.31e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—prostate cancer	5.72e-06	8.31e-05	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—prostate cancer	5.71e-06	8.3e-05	CcSEcCtD
Estropipate—Infection—Docetaxel—prostate cancer	5.68e-06	8.26e-05	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—prostate cancer	5.67e-06	8.25e-05	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—prostate cancer	5.66e-06	8.23e-05	CcSEcCtD
Estropipate—Diarrhoea—Mitoxantrone—prostate cancer	5.66e-06	8.23e-05	CcSEcCtD
Estropipate—Vomiting—Estradiol—prostate cancer	5.65e-06	8.21e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—prostate cancer	5.63e-06	8.18e-05	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—prostate cancer	5.61e-06	8.15e-05	CcSEcCtD
Estropipate—Rash—Estradiol—prostate cancer	5.6e-06	8.14e-05	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—prostate cancer	5.6e-06	8.14e-05	CcSEcCtD
Estropipate—Infestation—Doxorubicin—prostate cancer	5.6e-06	8.14e-05	CcSEcCtD
Estropipate—Dermatitis—Estradiol—prostate cancer	5.59e-06	8.13e-05	CcSEcCtD
Estropipate—Headache—Estradiol—prostate cancer	5.56e-06	8.09e-05	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—prostate cancer	5.56e-06	8.08e-05	CcSEcCtD
Estropipate—Oedema—Capecitabine—prostate cancer	5.54e-06	8.05e-05	CcSEcCtD
Estropipate—Angioedema—Prednisone—prostate cancer	5.52e-06	8.03e-05	CcSEcCtD
Estropipate—Infection—Capecitabine—prostate cancer	5.5e-06	8e-05	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—prostate cancer	5.49e-06	7.98e-05	CcSEcCtD
Estropipate—Urticaria—Etoposide—prostate cancer	5.47e-06	7.95e-05	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—prostate cancer	5.44e-06	7.91e-05	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—prostate cancer	5.44e-06	7.91e-05	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—prostate cancer	5.44e-06	7.91e-05	CcSEcCtD
Estropipate—Nervous system disorder—Capecitabine—prostate cancer	5.43e-06	7.89e-05	CcSEcCtD
Estropipate—Vertigo—Prednisone—prostate cancer	5.43e-06	7.89e-05	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—prostate cancer	5.39e-06	7.83e-05	CcSEcCtD
Estropipate—Skin disorder—Capecitabine—prostate cancer	5.38e-06	7.82e-05	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—prostate cancer	5.35e-06	7.78e-05	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—prostate cancer	5.29e-06	7.7e-05	CcSEcCtD
Estropipate—Nausea—Estradiol—prostate cancer	5.27e-06	7.67e-05	CcSEcCtD
Estropipate—Vomiting—Mitoxantrone—prostate cancer	5.26e-06	7.65e-05	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—prostate cancer	5.25e-06	7.63e-05	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—prostate cancer	5.23e-06	7.61e-05	CcSEcCtD
Estropipate—Rash—Mitoxantrone—prostate cancer	5.22e-06	7.58e-05	CcSEcCtD
Estropipate—Dermatitis—Mitoxantrone—prostate cancer	5.21e-06	7.58e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.21e-06	7.58e-05	CcSEcCtD
Estropipate—Headache—Mitoxantrone—prostate cancer	5.18e-06	7.54e-05	CcSEcCtD
Estropipate—Insomnia—Docetaxel—prostate cancer	5.17e-06	7.52e-05	CcSEcCtD
Estropipate—Myalgia—Prednisone—prostate cancer	5.15e-06	7.48e-05	CcSEcCtD
Estropipate—Arthralgia—Prednisone—prostate cancer	5.15e-06	7.48e-05	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—prostate cancer	5.14e-06	7.47e-05	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—prostate cancer	5.13e-06	7.46e-05	CcSEcCtD
Estropipate—Anxiety—Prednisone—prostate cancer	5.13e-06	7.45e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.11e-06	7.43e-05	CcSEcCtD
Estropipate—Somnolence—Docetaxel—prostate cancer	5.08e-06	7.39e-05	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—prostate cancer	5.07e-06	7.38e-05	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—prostate cancer	5.07e-06	7.37e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.04e-06	7.33e-05	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—prostate cancer	5.04e-06	7.33e-05	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—prostate cancer	5.04e-06	7.32e-05	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—prostate cancer	5.03e-06	7.32e-05	CcSEcCtD
Estropipate—Insomnia—Capecitabine—prostate cancer	5.01e-06	7.28e-05	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—prostate cancer	4.99e-06	7.25e-05	CcSEcCtD
Estropipate—Paraesthesia—Capecitabine—prostate cancer	4.97e-06	7.23e-05	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—prostate cancer	4.95e-06	7.2e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—prostate cancer	4.94e-06	7.18e-05	CcSEcCtD
Estropipate—Asthenia—Etoposide—prostate cancer	4.94e-06	7.18e-05	CcSEcCtD
Estropipate—Oedema—Prednisone—prostate cancer	4.93e-06	7.17e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—prostate cancer	4.93e-06	7.17e-05	CcSEcCtD
Estropipate—Fatigue—Docetaxel—prostate cancer	4.93e-06	7.17e-05	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—prostate cancer	4.93e-06	7.16e-05	CcSEcCtD
Estropipate—Nausea—Mitoxantrone—prostate cancer	4.91e-06	7.14e-05	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—prostate cancer	4.9e-06	7.13e-05	CcSEcCtD
Estropipate—Infection—Prednisone—prostate cancer	4.9e-06	7.12e-05	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—prostate cancer	4.89e-06	7.11e-05	CcSEcCtD
Estropipate—Constipation—Docetaxel—prostate cancer	4.89e-06	7.11e-05	CcSEcCtD
Estropipate—Pain—Docetaxel—prostate cancer	4.89e-06	7.11e-05	CcSEcCtD
Estropipate—Dyspepsia—Capecitabine—prostate cancer	4.87e-06	7.09e-05	CcSEcCtD
Estropipate—Pruritus—Etoposide—prostate cancer	4.87e-06	7.08e-05	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—prostate cancer	4.84e-06	7.04e-05	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—prostate cancer	4.84e-06	7.03e-05	CcSEcCtD
Estropipate—Alopecia—Epirubicin—prostate cancer	4.8e-06	6.98e-05	CcSEcCtD
Estropipate—Skin disorder—Prednisone—prostate cancer	4.79e-06	6.97e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Capecitabine—prostate cancer	4.78e-06	6.95e-05	CcSEcCtD
Estropipate—Fatigue—Capecitabine—prostate cancer	4.77e-06	6.94e-05	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—prostate cancer	4.76e-06	6.92e-05	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—prostate cancer	4.75e-06	6.91e-05	CcSEcCtD
Estropipate—Pain—Capecitabine—prostate cancer	4.74e-06	6.88e-05	CcSEcCtD
Estropipate—Constipation—Capecitabine—prostate cancer	4.74e-06	6.88e-05	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—prostate cancer	4.73e-06	6.87e-05	CcSEcCtD
Estropipate—Erythema—Epirubicin—prostate cancer	4.73e-06	6.87e-05	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—prostate cancer	4.71e-06	6.85e-05	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—prostate cancer	4.7e-06	6.83e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Docetaxel—prostate cancer	4.68e-06	6.8e-05	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—prostate cancer	4.66e-06	6.78e-05	CcSEcCtD
Estropipate—Flatulence—Epirubicin—prostate cancer	4.66e-06	6.77e-05	CcSEcCtD
Estropipate—Tension—Epirubicin—prostate cancer	4.64e-06	6.74e-05	CcSEcCtD
Estropipate—Nervousness—Epirubicin—prostate cancer	4.59e-06	6.67e-05	CcSEcCtD
Estropipate—Back pain—Epirubicin—prostate cancer	4.57e-06	6.65e-05	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—prostate cancer	4.56e-06	6.63e-05	CcSEcCtD
Estropipate—Dizziness—Etoposide—prostate cancer	4.55e-06	6.62e-05	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—prostate cancer	4.54e-06	6.61e-05	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—prostate cancer	4.54e-06	6.6e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Capecitabine—prostate cancer	4.53e-06	6.58e-05	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—prostate cancer	4.53e-06	6.58e-05	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—prostate cancer	4.52e-06	6.57e-05	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—prostate cancer	4.52e-06	6.57e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—prostate cancer	4.49e-06	6.53e-05	CcSEcCtD
Estropipate—Insomnia—Prednisone—prostate cancer	4.46e-06	6.49e-05	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—prostate cancer	4.44e-06	6.45e-05	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—prostate cancer	4.43e-06	6.44e-05	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—prostate cancer	4.4e-06	6.4e-05	CcSEcCtD
Estropipate—Urticaria—Capecitabine—prostate cancer	4.4e-06	6.4e-05	CcSEcCtD
Estropipate—Abdominal pain—Capecitabine—prostate cancer	4.38e-06	6.36e-05	CcSEcCtD
Estropipate—Body temperature increased—Capecitabine—prostate cancer	4.38e-06	6.36e-05	CcSEcCtD
Estropipate—Vomiting—Etoposide—prostate cancer	4.38e-06	6.36e-05	CcSEcCtD
Estropipate—Erythema—Doxorubicin—prostate cancer	4.37e-06	6.36e-05	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—prostate cancer	4.37e-06	6.36e-05	CcSEcCtD
Estropipate—Dyspepsia—Prednisone—prostate cancer	4.34e-06	6.31e-05	CcSEcCtD
Estropipate—Rash—Etoposide—prostate cancer	4.34e-06	6.31e-05	CcSEcCtD
Estropipate—Dermatitis—Etoposide—prostate cancer	4.34e-06	6.3e-05	CcSEcCtD
Estropipate—Headache—Etoposide—prostate cancer	4.31e-06	6.27e-05	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—prostate cancer	4.31e-06	6.27e-05	CcSEcCtD
Estropipate—Tension—Doxorubicin—prostate cancer	4.29e-06	6.24e-05	CcSEcCtD
Estropipate—Fatigue—Prednisone—prostate cancer	4.25e-06	6.18e-05	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—prostate cancer	4.25e-06	6.18e-05	CcSEcCtD
Estropipate—Vertigo—Epirubicin—prostate cancer	4.25e-06	6.17e-05	CcSEcCtD
Estropipate—Back pain—Doxorubicin—prostate cancer	4.23e-06	6.15e-05	CcSEcCtD
Estropipate—Constipation—Prednisone—prostate cancer	4.22e-06	6.13e-05	CcSEcCtD
Estropipate—Hypersensitivity—Docetaxel—prostate cancer	4.21e-06	6.13e-05	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—prostate cancer	4.2e-06	6.11e-05	CcSEcCtD
Estropipate—Palpitations—Epirubicin—prostate cancer	4.18e-06	6.07e-05	CcSEcCtD
Estropipate—Cough—Epirubicin—prostate cancer	4.12e-06	6e-05	CcSEcCtD
Estropipate—Asthenia—Docetaxel—prostate cancer	4.1e-06	5.97e-05	CcSEcCtD
Estropipate—Nausea—Etoposide—prostate cancer	4.09e-06	5.94e-05	CcSEcCtD
Estropipate—Hypersensitivity—Capecitabine—prostate cancer	4.08e-06	5.93e-05	CcSEcCtD
Estropipate—Pruritus—Docetaxel—prostate cancer	4.05e-06	5.88e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Prednisone—prostate cancer	4.03e-06	5.86e-05	CcSEcCtD
Estropipate—Myalgia—Epirubicin—prostate cancer	4.02e-06	5.85e-05	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—prostate cancer	4.02e-06	5.85e-05	CcSEcCtD
Estropipate—Anxiety—Epirubicin—prostate cancer	4.01e-06	5.83e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4e-06	5.81e-05	CcSEcCtD
Estropipate—Asthenia—Capecitabine—prostate cancer	3.97e-06	5.78e-05	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—prostate cancer	3.93e-06	5.71e-05	CcSEcCtD
Estropipate—Urticaria—Prednisone—prostate cancer	3.92e-06	5.7e-05	CcSEcCtD
Estropipate—Pruritus—Capecitabine—prostate cancer	3.92e-06	5.7e-05	CcSEcCtD
Estropipate—Diarrhoea—Docetaxel—prostate cancer	3.91e-06	5.69e-05	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—prostate cancer	3.9e-06	5.67e-05	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—prostate cancer	3.9e-06	5.67e-05	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—prostate cancer	3.86e-06	5.62e-05	CcSEcCtD
Estropipate—Oedema—Epirubicin—prostate cancer	3.86e-06	5.61e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—prostate cancer	3.86e-06	5.61e-05	CcSEcCtD
Estropipate—Infection—Epirubicin—prostate cancer	3.83e-06	5.57e-05	CcSEcCtD
Estropipate—Cough—Doxorubicin—prostate cancer	3.82e-06	5.55e-05	CcSEcCtD
Estropipate—Diarrhoea—Capecitabine—prostate cancer	3.79e-06	5.51e-05	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—prostate cancer	3.78e-06	5.5e-05	CcSEcCtD
Estropipate—Dizziness—Docetaxel—prostate cancer	3.78e-06	5.5e-05	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—prostate cancer	3.75e-06	5.45e-05	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—prostate cancer	3.72e-06	5.41e-05	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—prostate cancer	3.72e-06	5.41e-05	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—prostate cancer	3.71e-06	5.39e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.7e-06	5.38e-05	CcSEcCtD
Estropipate—Dizziness—Capecitabine—prostate cancer	3.66e-06	5.32e-05	CcSEcCtD
Estropipate—Vomiting—Docetaxel—prostate cancer	3.64e-06	5.29e-05	CcSEcCtD
Estropipate—Hypersensitivity—Prednisone—prostate cancer	3.63e-06	5.28e-05	CcSEcCtD
Estropipate—Rash—Docetaxel—prostate cancer	3.61e-06	5.24e-05	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—prostate cancer	3.6e-06	5.24e-05	CcSEcCtD
Estropipate—Headache—Docetaxel—prostate cancer	3.58e-06	5.21e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—prostate cancer	3.57e-06	5.19e-05	CcSEcCtD
Estropipate—Oedema—Doxorubicin—prostate cancer	3.57e-06	5.19e-05	CcSEcCtD
Estropipate—Infection—Doxorubicin—prostate cancer	3.55e-06	5.16e-05	CcSEcCtD
Estropipate—Asthenia—Prednisone—prostate cancer	3.54e-06	5.14e-05	CcSEcCtD
Estropipate—Vomiting—Capecitabine—prostate cancer	3.52e-06	5.12e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.51e-06	5.11e-05	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—prostate cancer	3.5e-06	5.09e-05	CcSEcCtD
Estropipate—Rash—Capecitabine—prostate cancer	3.49e-06	5.08e-05	CcSEcCtD
Estropipate—Pruritus—Prednisone—prostate cancer	3.49e-06	5.07e-05	CcSEcCtD
Estropipate—Insomnia—Epirubicin—prostate cancer	3.49e-06	5.07e-05	CcSEcCtD
Estropipate—Dermatitis—Capecitabine—prostate cancer	3.49e-06	5.07e-05	CcSEcCtD
Estropipate—Headache—Capecitabine—prostate cancer	3.47e-06	5.04e-05	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—prostate cancer	3.47e-06	5.04e-05	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—prostate cancer	3.46e-06	5.04e-05	CcSEcCtD
Estropipate—Somnolence—Epirubicin—prostate cancer	3.43e-06	4.99e-05	CcSEcCtD
Estropipate—Nausea—Docetaxel—prostate cancer	3.4e-06	4.94e-05	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—prostate cancer	3.4e-06	4.94e-05	CcSEcCtD
Estropipate—Diarrhoea—Prednisone—prostate cancer	3.37e-06	4.91e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—prostate cancer	3.33e-06	4.84e-05	CcSEcCtD
Estropipate—Fatigue—Epirubicin—prostate cancer	3.33e-06	4.84e-05	CcSEcCtD
Estropipate—Pain—Epirubicin—prostate cancer	3.3e-06	4.8e-05	CcSEcCtD
Estropipate—Constipation—Epirubicin—prostate cancer	3.3e-06	4.8e-05	CcSEcCtD
Estropipate—Nausea—Capecitabine—prostate cancer	3.29e-06	4.78e-05	CcSEcCtD
Estropipate—Dizziness—Prednisone—prostate cancer	3.26e-06	4.74e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.25e-06	4.73e-05	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—prostate cancer	3.23e-06	4.69e-05	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—prostate cancer	3.21e-06	4.66e-05	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—prostate cancer	3.17e-06	4.61e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—prostate cancer	3.15e-06	4.59e-05	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—prostate cancer	3.14e-06	4.57e-05	CcSEcCtD
Estropipate—Vomiting—Prednisone—prostate cancer	3.14e-06	4.56e-05	CcSEcCtD
Estropipate—Rash—Prednisone—prostate cancer	3.11e-06	4.52e-05	CcSEcCtD
Estropipate—Dermatitis—Prednisone—prostate cancer	3.11e-06	4.52e-05	CcSEcCtD
Estropipate—Headache—Prednisone—prostate cancer	3.09e-06	4.49e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.08e-06	4.48e-05	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—prostate cancer	3.08e-06	4.47e-05	CcSEcCtD
Estropipate—Urticaria—Epirubicin—prostate cancer	3.06e-06	4.46e-05	CcSEcCtD
Estropipate—Pain—Doxorubicin—prostate cancer	3.05e-06	4.44e-05	CcSEcCtD
Estropipate—Constipation—Doxorubicin—prostate cancer	3.05e-06	4.44e-05	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—prostate cancer	3.05e-06	4.43e-05	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—prostate cancer	3.05e-06	4.43e-05	CcSEcCtD
Estropipate—Nausea—Prednisone—prostate cancer	2.93e-06	4.26e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—prostate cancer	2.92e-06	4.24e-05	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—prostate cancer	2.84e-06	4.13e-05	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—prostate cancer	2.84e-06	4.12e-05	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—prostate cancer	2.82e-06	4.1e-05	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—prostate cancer	2.82e-06	4.1e-05	CcSEcCtD
Estropipate—Asthenia—Epirubicin—prostate cancer	2.77e-06	4.02e-05	CcSEcCtD
Estropipate—Pruritus—Epirubicin—prostate cancer	2.73e-06	3.97e-05	CcSEcCtD
Estropipate—Diarrhoea—Epirubicin—prostate cancer	2.64e-06	3.84e-05	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—prostate cancer	2.63e-06	3.82e-05	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—prostate cancer	2.56e-06	3.72e-05	CcSEcCtD
Estropipate—Dizziness—Epirubicin—prostate cancer	2.55e-06	3.71e-05	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—prostate cancer	2.53e-06	3.67e-05	CcSEcCtD
Estropipate—Vomiting—Epirubicin—prostate cancer	2.45e-06	3.57e-05	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—prostate cancer	2.44e-06	3.55e-05	CcSEcCtD
Estropipate—Rash—Epirubicin—prostate cancer	2.43e-06	3.54e-05	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—prostate cancer	2.43e-06	3.53e-05	CcSEcCtD
Estropipate—Headache—Epirubicin—prostate cancer	2.42e-06	3.51e-05	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—prostate cancer	2.36e-06	3.43e-05	CcSEcCtD
Estropipate—Nausea—Epirubicin—prostate cancer	2.29e-06	3.33e-05	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—prostate cancer	2.27e-06	3.3e-05	CcSEcCtD
Estropipate—Rash—Doxorubicin—prostate cancer	2.25e-06	3.27e-05	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—prostate cancer	2.25e-06	3.27e-05	CcSEcCtD
Estropipate—Headache—Doxorubicin—prostate cancer	2.24e-06	3.25e-05	CcSEcCtD
Estropipate—Nausea—Doxorubicin—prostate cancer	2.12e-06	3.08e-05	CcSEcCtD
Estropipate—CYP1A2—Metabolism—MED12—prostate cancer	1.03e-06	3.93e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.02e-06	3.91e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GNG5—prostate cancer	1.02e-06	3.9e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PRKACB—prostate cancer	1.01e-06	3.89e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.01e-06	3.88e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.01e-06	3.88e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—prostate cancer	1.01e-06	3.86e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CAV1—prostate cancer	1.01e-06	3.85e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP17A1—prostate cancer	1e-06	3.85e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GGT1—prostate cancer	1e-06	3.83e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.91e-07	3.79e-05	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—prostate cancer	9.88e-07	3.78e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—NCOA1—prostate cancer	9.85e-07	3.77e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOA3—prostate cancer	9.8e-07	3.75e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP19A1—prostate cancer	9.71e-07	3.72e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA4—prostate cancer	9.71e-07	3.72e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.71e-07	3.72e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HIF1A—prostate cancer	9.64e-07	3.69e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	9.63e-07	3.69e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOA2—prostate cancer	9.57e-07	3.67e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—prostate cancer	9.55e-07	3.66e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA2—prostate cancer	9.46e-07	3.62e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—LEP—prostate cancer	9.41e-07	3.6e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—RXRA—prostate cancer	9.37e-07	3.59e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPGDS—prostate cancer	9.35e-07	3.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCG5—prostate cancer	9.34e-07	3.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SULT1A1—prostate cancer	9.34e-07	3.58e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CAV1—prostate cancer	9.32e-07	3.57e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2C19—prostate cancer	9.29e-07	3.56e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—prostate cancer	9.28e-07	3.56e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KDR—prostate cancer	9.22e-07	3.53e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—prostate cancer	9.16e-07	3.51e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A5—prostate cancer	9.13e-07	3.5e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTA1—prostate cancer	9.13e-07	3.5e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.11e-07	3.49e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ACHE—prostate cancer	9.07e-07	3.47e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—prostate cancer	9.07e-07	3.47e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—prostate cancer	9.04e-07	3.46e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—COMT—prostate cancer	9.03e-07	3.46e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.02e-07	3.46e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NAT2—prostate cancer	9.02e-07	3.46e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTO1—prostate cancer	9.02e-07	3.46e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—prostate cancer	8.98e-07	3.44e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2A6—prostate cancer	8.96e-07	3.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	8.93e-07	3.42e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP2E1—prostate cancer	8.92e-07	3.42e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ITPR1—prostate cancer	8.84e-07	3.39e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NQO1—prostate cancer	8.82e-07	3.38e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BAD—prostate cancer	8.77e-07	3.36e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKR1C3—prostate cancer	8.72e-07	3.34e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.69e-07	3.33e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TH—prostate cancer	8.69e-07	3.33e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—INS—prostate cancer	8.68e-07	3.32e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PRKACB—prostate cancer	8.67e-07	3.32e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PLCB2—prostate cancer	8.65e-07	3.31e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—LRP2—prostate cancer	8.65e-07	3.31e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.65e-07	3.31e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.63e-07	3.31e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP3A4—prostate cancer	8.6e-07	3.29e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP17A1—prostate cancer	8.58e-07	3.29e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.56e-07	3.28e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CREBBP—prostate cancer	8.5e-07	3.25e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—prostate cancer	8.49e-07	3.25e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APC—prostate cancer	8.49e-07	3.25e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—P4HB—prostate cancer	8.48e-07	3.25e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.46e-07	3.24e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1B1—prostate cancer	8.45e-07	3.24e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGF—prostate cancer	8.39e-07	3.21e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IRS1—prostate cancer	8.39e-07	3.21e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—TYMS—prostate cancer	8.35e-07	3.2e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—prostate cancer	8.3e-07	3.18e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—prostate cancer	8.26e-07	3.16e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.25e-07	3.16e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GGT1—prostate cancer	8.19e-07	3.14e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOA2—prostate cancer	8.18e-07	3.13e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—GSK3B—prostate cancer	8.15e-07	3.12e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—LPL—prostate cancer	8.1e-07	3.1e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOA1—prostate cancer	8.06e-07	3.09e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—prostate cancer	8.06e-07	3.09e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.04e-07	3.08e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—INS—prostate cancer	8.04e-07	3.08e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP19A1—prostate cancer	7.95e-07	3.04e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MED12—prostate cancer	7.91e-07	3.03e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREBBP—prostate cancer	7.87e-07	3.01e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GNG5—prostate cancer	7.85e-07	3.01e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP1A1—prostate cancer	7.83e-07	3e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A5—prostate cancer	7.8e-07	2.99e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IGF1—prostate cancer	7.77e-07	2.98e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ERCC2—prostate cancer	7.76e-07	2.97e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—prostate cancer	7.69e-07	2.94e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RXRA—prostate cancer	7.67e-07	2.94e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2E1—prostate cancer	7.62e-07	2.92e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NOS3—prostate cancer	7.61e-07	2.91e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOA3—prostate cancer	7.56e-07	2.9e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NQO1—prostate cancer	7.53e-07	2.89e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAP2K1—prostate cancer	7.51e-07	2.88e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—prostate cancer	7.46e-07	2.86e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.46e-07	2.86e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TH—prostate cancer	7.43e-07	2.84e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—COMT—prostate cancer	7.39e-07	2.83e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SERPINE1—prostate cancer	7.38e-07	2.83e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.38e-07	2.83e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—prostate cancer	7.35e-07	2.82e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP3A4—prostate cancer	7.35e-07	2.81e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.31e-07	2.8e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTHFR—prostate cancer	7.3e-07	2.79e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ITPR1—prostate cancer	7.24e-07	2.77e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1B1—prostate cancer	7.22e-07	2.77e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPGDS—prostate cancer	7.21e-07	2.76e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—prostate cancer	7.18e-07	2.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.17e-07	2.75e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARA—prostate cancer	7.16e-07	2.74e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGF2—prostate cancer	7.15e-07	2.74e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.12e-07	2.73e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—prostate cancer	7.06e-07	2.71e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NOS3—prostate cancer	7.05e-07	2.7e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—prostate cancer	7.02e-07	2.69e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—prostate cancer	7e-07	2.68e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ACHE—prostate cancer	7e-07	2.68e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GGT1—prostate cancer	7e-07	2.68e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—prostate cancer	6.96e-07	2.67e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.92e-07	2.65e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOA1—prostate cancer	6.89e-07	2.64e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JAK2—prostate cancer	6.85e-07	2.62e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TYMS—prostate cancer	6.84e-07	2.62e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—prostate cancer	6.83e-07	2.62e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP19A1—prostate cancer	6.79e-07	2.6e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—prostate cancer	6.76e-07	2.59e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CAV1—prostate cancer	6.73e-07	2.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.73e-07	2.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PRKACB—prostate cancer	6.69e-07	2.56e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—prostate cancer	6.69e-07	2.56e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—LPL—prostate cancer	6.63e-07	2.54e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.62e-07	2.54e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—ERBB2—prostate cancer	6.59e-07	2.52e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RXRA—prostate cancer	6.55e-07	2.51e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—prostate cancer	6.5e-07	2.49e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.43e-07	2.46e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.41e-07	2.45e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.38e-07	2.44e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ERCC2—prostate cancer	6.35e-07	2.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—COMT—prostate cancer	6.31e-07	2.42e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOA2—prostate cancer	6.31e-07	2.42e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—prostate cancer	6.28e-07	2.41e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—prostate cancer	6.25e-07	2.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ITPR1—prostate cancer	6.18e-07	2.37e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—prostate cancer	6.13e-07	2.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—prostate cancer	6.1e-07	2.34e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.08e-07	2.33e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—prostate cancer	6.07e-07	2.32e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.02e-07	2.31e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—prostate cancer	5.98e-07	2.29e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—prostate cancer	5.97e-07	2.29e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTHFR—prostate cancer	5.97e-07	2.29e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.88e-07	2.25e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARA—prostate cancer	5.86e-07	2.24e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TYMS—prostate cancer	5.84e-07	2.24e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—prostate cancer	5.82e-07	2.23e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NQO1—prostate cancer	5.82e-07	2.23e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—INS—prostate cancer	5.8e-07	2.22e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—prostate cancer	5.79e-07	2.22e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—prostate cancer	5.78e-07	2.21e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—prostate cancer	5.77e-07	2.21e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CTNNB1—prostate cancer	5.77e-07	2.21e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TH—prostate cancer	5.73e-07	2.2e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CREBBP—prostate cancer	5.68e-07	2.18e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—LPL—prostate cancer	5.67e-07	2.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MMP9—prostate cancer	5.65e-07	2.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—prostate cancer	5.63e-07	2.16e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—prostate cancer	5.62e-07	2.15e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.58e-07	2.14e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CAV1—prostate cancer	5.51e-07	2.11e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.47e-07	2.1e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ERCC2—prostate cancer	5.43e-07	2.08e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GGT1—prostate cancer	5.4e-07	2.07e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—prostate cancer	5.39e-07	2.06e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—prostate cancer	5.36e-07	2.05e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOA1—prostate cancer	5.32e-07	2.04e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.26e-07	2.02e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.24e-07	2.01e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—prostate cancer	5.21e-07	2e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTHFR—prostate cancer	5.1e-07	1.95e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—NOS3—prostate cancer	5.09e-07	1.95e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—prostate cancer	5.08e-07	1.94e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RXRA—prostate cancer	5.06e-07	1.94e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—prostate cancer	5.03e-07	1.93e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.02e-07	1.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARA—prostate cancer	5.01e-07	1.92e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—prostate cancer	4.98e-07	1.91e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—COMT—prostate cancer	4.87e-07	1.87e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—prostate cancer	4.85e-07	1.86e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ITPR1—prostate cancer	4.77e-07	1.83e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—INS—prostate cancer	4.75e-07	1.82e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CAV1—prostate cancer	4.71e-07	1.8e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—prostate cancer	4.7e-07	1.8e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—prostate cancer	4.67e-07	1.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—prostate cancer	4.66e-07	1.78e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—prostate cancer	4.65e-07	1.78e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CREBBP—prostate cancer	4.65e-07	1.78e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EGFR—prostate cancer	4.57e-07	1.75e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TYMS—prostate cancer	4.51e-07	1.73e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.5e-07	1.72e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—prostate cancer	4.46e-07	1.71e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.41e-07	1.69e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—LPL—prostate cancer	4.37e-07	1.68e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—prostate cancer	4.32e-07	1.65e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.29e-07	1.64e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—prostate cancer	4.28e-07	1.64e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.23e-07	1.62e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ERCC2—prostate cancer	4.19e-07	1.61e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NOS3—prostate cancer	4.17e-07	1.6e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—prostate cancer	4.06e-07	1.55e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—INS—prostate cancer	4.06e-07	1.55e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CREBBP—prostate cancer	3.98e-07	1.52e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—prostate cancer	3.97e-07	1.52e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTHFR—prostate cancer	3.94e-07	1.51e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—prostate cancer	3.87e-07	1.48e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARA—prostate cancer	3.86e-07	1.48e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.85e-07	1.47e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—prostate cancer	3.84e-07	1.47e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—prostate cancer	3.81e-07	1.46e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.77e-07	1.44e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CAV1—prostate cancer	3.63e-07	1.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NOS3—prostate cancer	3.56e-07	1.36e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—prostate cancer	3.51e-07	1.34e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—prostate cancer	3.5e-07	1.34e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—prostate cancer	3.32e-07	1.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.31e-07	1.27e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.29e-07	1.26e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—prostate cancer	3.26e-07	1.25e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—prostate cancer	3.24e-07	1.24e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—prostate cancer	3.17e-07	1.21e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—INS—prostate cancer	3.13e-07	1.2e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CREBBP—prostate cancer	3.07e-07	1.18e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.91e-07	1.11e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—prostate cancer	2.86e-07	1.1e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—prostate cancer	2.84e-07	1.09e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NOS3—prostate cancer	2.75e-07	1.05e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—prostate cancer	2.71e-07	1.04e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.54e-07	9.71e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—prostate cancer	2.51e-07	9.62e-06	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.34e-07	8.98e-06	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—prostate cancer	2.34e-07	8.96e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—prostate cancer	2.19e-07	8.39e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—prostate cancer	2.09e-07	8e-06	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—prostate cancer	2e-07	7.67e-06	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—prostate cancer	1.91e-07	7.33e-06	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—prostate cancer	1.64e-07	6.27e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.55e-07	5.92e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—prostate cancer	1.26e-07	4.84e-06	CbGpPWpGaD
